These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16352456)

  • 1. Systemic lupus-erythematosus: deoxyribonuclease 1 in necrotic chromatin disposal.
    Napirei M; Gültekin A; Kloeckl T; Möröy T; Frostegård J; Mannherz HG
    Int J Biochem Cell Biol; 2006 Mar; 38(3):297-306. PubMed ID: 16352456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus, DNase and defective disposal of cellular debris.
    Walport MJ
    Nat Genet; 2000 Jun; 25(2):135-6. PubMed ID: 10835621
    [No Abstract]   [Full Text] [Related]  

  • 3. Features of systemic lupus erythematosus in Dnase1-deficient mice.
    Napirei M; Karsunky H; Zevnik B; Stephan H; Mannherz HG; Möröy T
    Nat Genet; 2000 Jun; 25(2):177-81. PubMed ID: 10835632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNase 1 and systemic lupus erythematosus.
    Martínez Valle F; Balada E; Ordi-Ros J; Vilardell-Tarres M
    Autoimmun Rev; 2008 May; 7(5):359-63. PubMed ID: 18486922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system.
    Napirei M; Wulf S; Mannherz HG
    Arthritis Rheum; 2004 Jun; 50(6):1873-83. PubMed ID: 15188364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA as a marker of cell death in systemic lupus erythematosus.
    Pisetsky DS
    Rheum Dis Clin North Am; 2004 Aug; 30(3):575-87, x. PubMed ID: 15261342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.
    Mortensen ES; Rekvig OP
    J Am Soc Nephrol; 2009 Apr; 20(4):696-704. PubMed ID: 19329762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin.
    Gaipl US; Beyer TD; Heyder P; Kuenkele S; Böttcher A; Voll RE; Kalden JR; Herrmann M
    Arthritis Rheum; 2004 Feb; 50(2):640-9. PubMed ID: 14872509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of extracellular DNA in autoimmunity in SLE.
    Su KY; Pisetsky DS
    Scand J Immunol; 2009 Sep; 70(3):175-83. PubMed ID: 19703007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus.
    Dieker JW; Fransen JH; van Bavel CC; Briand JP; Jacobs CW; Muller S; Berden JH; van der Vlag J
    Arthritis Rheum; 2007 Jun; 56(6):1921-33. PubMed ID: 17530637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNaseI in pathogenesis of systemic lupus erythematosus.
    Tsukumo S; Yasutomo K
    Clin Immunol; 2004 Oct; 113(1):14-8. PubMed ID: 15380524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
    Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
    Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel DNASE I mutations related to systemic lupus erythematosus.
    Bodaño A; Amarelo J; González A; Gómez-Reino JJ; Conde C
    Arthritis Rheum; 2004 Dec; 50(12):4070-1. PubMed ID: 15593183
    [No Abstract]   [Full Text] [Related]  

  • 15. Apoptosis and systemic lupus erythematosus.
    Sheriff A; Gaipl US; Voll RE; Kalden JR; Herrmann M
    Rheum Dis Clin North Am; 2004 Aug; 30(3):505-27, viii-ix. PubMed ID: 15261339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
    Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
    Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.
    Grimaldi CM
    Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
    Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
    Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SLE caused by DNase 1 gene mutation].
    Tao K; Yasutomo K
    Nihon Rinsho; 2005 May; 63 Suppl 5():205-9. PubMed ID: 15954350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.